Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

This Metric Says You Are Smart to Buy Consolidated Graphics, Inc. (CGX)

Page 1 of 2

Consolidated Graphics, Inc. (NYSE:CGX) has experienced an increase in enthusiasm from smart money in recent months.

At the moment, there are dozens of metrics investors can use to track their holdings. A duo of the best are hedge fund and insider trading sentiment. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best fund managers can trounce the market by a significant margin (see just how much).

Consolidated Graphics, Inc. (NYSE:CGX)

Just as key, positive insider trading sentiment is another way to break down the stock market universe. As the old adage goes: there are plenty of reasons for a corporate insider to sell shares of his or her company, but only one, very clear reason why they would initiate a purchase. Many empirical studies have demonstrated the useful potential of this method if you understand where to look (learn more here).

Consequently, it’s important to take a gander at the latest action regarding Consolidated Graphics, Inc. (NYSE:CGX).

What does the smart money think about Consolidated Graphics, Inc. (NYSE:CGX)?

Heading into 2013, a total of 9 of the hedge funds we track were bullish in this stock, a change of 29% from the third quarter. With hedge funds’ sentiment swirling, there exists an “upper tier” of noteworthy hedge fund managers who were upping their stakes considerably.

When looking at the hedgies we track, Algert Coldiron Investors, managed by Peter Algert and Kevin Coldiron, holds the largest position in Consolidated Graphics, Inc. (NYSE:CGX). Algert Coldiron Investors has a $2.6 million position in the stock, comprising 0.8% of its 13F portfolio. The second largest stake is held by Jim Simons of Renaissance Technologies, with a $1.7 million position; less than 0.1%% of its 13F portfolio is allocated to the company. Other hedgies that are bullish include Joel Greenblatt’s Gotham Asset Management, Israel Englander’s Millennium Management and Cliff Asness’s AQR Capital Management.

Consequently, specific money managers were breaking ground themselves. Gotham Asset Management, managed by Joel Greenblatt, created the most valuable position in Consolidated Graphics, Inc. (NYSE:CGX). Gotham Asset Management had 1.6 million invested in the company at the end of the quarter. Israel Englander’s Millennium Management also initiated a $1.4 million position during the quarter. The other funds with new positions in the stock are Neil Chriss’s Hutchin Hill Capital and Charles Davidson’s Wexford Capital.

How have insiders been trading Consolidated Graphics, Inc. (NYSE:CGX)?

Insider buying is at its handiest when the company in question has seen transactions within the past half-year. Over the latest 180-day time frame, Consolidated Graphics, Inc. (NYSE:CGX) has experienced 1 unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to Consolidated Graphics, Inc. (NYSE:CGX). These stocks are Safeguard Scientifics, Inc (NYSE:SFE), Net 1 UEPS Technologies Inc (NASDAQ:UEPS), Multi-Color Corporation (NASDAQ:LABL), Higher One Holdings, Inc (NYSE:ONE), and Furiex Pharmaceuticals Inc (NASDAQ:FURX). This group of stocks belong to the business services industry and their market caps resemble CGX’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!